Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?



Pfizer Tops Estimates in Second Quarter, Reiterates Full Year Outlook

By  +Follow July 30, 2013 8:52AM
Tickers Mentioned:

Pfizer Inc. (PFE) , the biggest drugmaker in the world, on Tuesday reported second-quarter earnings that nipped past analyst predictions as the company fought through declining sales that were hamstringed by the loss of exclusivity on the blockbuster cholesterol fighter Lipitor.

For the quarter, NYC-based Pfizer said it generated $12.97 billion in revenue, compared to $13.97 billion in the second quarter last year.  Net income soared to $14.1 billion, or $1.98 per share, versus $3.25 billion, or 43 cents per share, in last year’s quarter.  In February, Pfizer spun-out its animal health business into a new company called Zoetis, Inc. (ZTS) .  In December 2012, it sold its nutrition business to Nestle SA ($NSRGY) for $11.85 billion, accounting for most of the surge in reported income.  Excluding gains from the sale, restructuring costs and other special items, adjusted profits for the second quarter totaled $4.0 billion, or 56 cents per share, compared to $4.45 billion, or 59 cents per share, in the year prior quarter.

Wall Street was expecting EPS of 55 cents on revenue of $13.01 billion.

Sales of Lipitor sank 55 percent from $1.22 billion in the second quarter of 2012 to $545 million in the latest quarter.  Sales of pneumococcal vaccine Prevnar slipped 3 percent to $969 million due to changes in government purchasing patterns.  Counterbalancing those losses, sales of Pfizer’s biggest drug Lyrica, which is indicated for fibromyalgia, diabetic nerve pain and more, improved by 10 percent to $1.13 billion.

Revenue for Pfizer’s leading business units – primary care, specialty care, emerging markets and established products – all declined compared to the year prior quarter.  Ian Read, chairman and chief executive at Pfizer, said in today’s statement that he expects emerging market business growth to accelerate in the second of the year, led by China.

“From a total company view, we are tracking to our expectations for the full year and continue to capitalize on the investments we are making to better position Pfizer for long-term success,” added Read.

The company backed its 2013 forecast of adjusted earnings in the range of $2.10 to $2.20 per share.

Sales of anti-cancer drugs rose 24 percent to $399 million, boosted in part by a 191-percent climb in sales of Xalkori to $67 million and $17 million in sales from new drug Inlyta.

Operating margin improved significantly from 29.9 percent to 41.3 percent.

Marking “the next step in Pfizer’s journey to further revitalize [its] innovative core,” Pfizer said on Monday that it intends to split its company into three new units.  One unit will focus on drugs that are patent-protected beyond 2015.  The second will include vaccines, oncology and consumer healthcare products.  The third will include drugs that have lost – or will soon lose – patent exclusivity, generics and future product collaborations.  The changes are slated to start happening in January.

Two new drugs, blood thinner Eliquis and rheumatoid arthritis drug Xeljanz, are thought by many to have the capabilities to grow into blockbusters, although Zeljanz is facing some hurdles in Europe with negative opinions being offered by a European Medicines Agency committee.  Zeljanz generated $33 million in sales in the second quarter. The FDA is reviewing a supplemental New Drug Application (NDA) for Zeljanz with a decision expected by February.  Topline results are expected from two ongoing phase 3 trials evaluating Zeljanz in the second quarter next year.  The FDA is also reviewing a supplemental NDA for Eliquis, with a decision expected by March 15, 2014. 

During the second quarter, Pfizer repurchased $3.3 billion worth of its common stock, bringing its first-half total to $8.7 billion.

Shares of PFE have risen 20 percent so far in 2013 through Monday’s close at $29.54.  

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for PFE
23 May 15 00:45:04
PPA PowerShares Aerospace and Defense Portfolio Bid http://t.co/gAHuoTiXqD $PPA $XLY $PFE $GOOG #PPA #stockmarket #pennystocks
23 May 15 00:44:36
PFE Pfizer, Inc. Dividend http://t.co/2S2qrSKCdM $PFE $SYN $CI $PM #PFE #stocks #stockmarket
23 May 15 00:44:34
PFE Pfizer, Inc. Company Info http://t.co/E43xocXf8g $PFE $FXB $ADT $FXCM #PFE #finance #tradeideas
Capital Market Labs
23 May 15 00:42:01
Largest Pharmaceuticals, Biotechnology and Life Sciences Assets $INCY $PFE $TEVA Chart: http://t.co/mJlM6sICxA http://t.co/Z0ax8o5cZq
23 May 15 00:41:41
GNW Genworth Financial Inc. Current Price http://t.co/IEzqy51XrH $GNW $DGX $PFE $IBB #GNW #pennystocks #stockGOOG Google Inc. - Class…
23 May 15 00:41:16
GNW Genworth Financial Inc. Current Price http://t.co/MAuQqXIIw3 $GNW $DGX $PFE $IBB #GNW #pennystocks #stockGOOG Google Inc. - Class…
23 May 15 00:41:15
GNW Genworth Financial Inc. Current Price http://t.co/ni6jCRhGSu $GNW $DGX $PFE $IBB #GNW #pennystocks #stockGOOG Google Inc. - Class…
23 May 15 00:41:11
GNW Genworth Financial Inc. Current Price http://t.co/bxoxYw0oy7 $GNW $DGX $PFE $IBB #GNW #pennystocks #stockGOOG Google Inc. - Class…
Capital Market Labs
23 May 15 00:41:11
Largest Pharmaceuticals, Biotechnology and Life Sciences Assets $INCY $PFE $TEVA Chart: http://t.co/mJlM6sICxA http://t.co/Xb1dCo7BLv
23 May 15 00:41:09
GNW Genworth Financial Inc. Current Price http://t.co/ZBwRKdPNvW $GNW $DGX $PFE $IBB #GNW #pennystocks #stockGOOG Google Inc. - Class…
23 May 15 00:41:09
GNW Genworth Financial Inc. Current Price http://t.co/sSKZdlBAn5 $GNW $DGX $PFE $IBB #GNW #pennystocks #stock
23 May 15 00:39:30
FEYE FireEye Inc. Day Low http://t.co/EH5sR8m1Mp $FEYE $DBC $PFE $EWY #FEYE #investing #finance
23 May 15 00:39:09
EWS Singapore iShares % Change http://t.co/9Y2MG9btqK $EWS $BMY $PFE $CYBR #EWS #stocks #finance
Investors Hangout
23 May 15 00:38:13
DXJ Wisdom Tree Japan Hedged Equity Filings http://t.co/uaTYejnB1A $DXJ $PFE $CI $GILD #DXJ #invest #tradeideas
23 May 15 00:38:11
DDD 3D Systems Corp. Tick http://t.co/RiZDYNNCUG $DDD $DXJ $GE $PFE #DDD #stock #finance
23 May 15 00:35:13
BTU Peabody Energy Corp. Chart http://t.co/DrApB1ZaZp $BTU $TQQQ $PFE $CIG #BTU #pennystocks #share
Capital Market Labs
22 May 15 23:17:56
$PFE vs. $BMY vs. $JNJ vs. $MRK Compared Across 9 Critical Measures http://t.co/amd6K5VLvN http://t.co/DGZ99e7QSl
Swathi Allada
22 May 15 21:54:14
RT @FiercePharma: Pfizer could buy GSK, but would Shire or Perrigo offer better targets? http://t.co/JpkkjiyL77 $PFE $GSK $SHPG $PRGO #phar…
22 May 15 21:50:09
XIV VelocityShares Daily Inverse VIX Short Term ETN Prev Close http://t.co/HBJxZ9BVtt $XIV $ALK $PFE $BABL #XIV #finance #pennystocks
Lucky Jimmy
22 May 15 21:48:38
UNGS US Natural Gas Corp. Open http://t.co/a5g7apZLu7 $UNGS $PFE $FWDG $GLOW #UNGS #stocks #finance
22 May 15 21:45:08
PFE Pfizer, Inc. Day High http://t.co/fhfz56XtoZ $PFE $TWTR $DE $CVS #PFE #stock #nasdaq
Investors Hangout
22 May 15 21:45:05
PFE Pfizer, Inc. Quotes http://t.co/qNQBqit2ib $PFE $ITB $DIA $XIV #PFE #tradeideas #stockmarket
IH News Desk
22 May 15 21:45:04
PFE Pfizer, Inc. Market Cap http://t.co/DkskHFfgBh $PFE $BHYAX $XLE $CTIX #PFE #investing #finance
Lucky Jimmy
22 May 15 21:45:03
PFE Pfizer, Inc. Yield http://t.co/Eln0Z40Hu2 $PFE $INTC $GDDY $BIDU #PFE #tradeideas #pennystocks
22 May 15 21:44:12
MLI Mueller Industries Inc. % Change http://t.co/uFgVOjQV11 $MLI $EGRX $LUV $PFE #MLI #stockmarket #investing
22 May 15 21:39:05
EUO ProShares UltraShort Euro Day Low http://t.co/e0GFmGVDXM $EUO $EBAY $PFE $LIFE #EUO #finance #nasdaq
22 May 15 21:35:41
CELG Celgene Corp. Ask http://t.co/p2pkUhy0Jv $CELG $ECIG $PFE $WYNN #CELG #investing #finance
Lucky Jimmy
22 May 15 21:35:36
CLDN Celladon Corp. Stock Message Board http://t.co/Rtsskm1taK $CLDN $BAC $SSE $PFE #CLDN #finance #stock
22 May 15 21:35:08
BTU Peabody Energy Corp. Stock Forum http://t.co/8QECRChkE9 $BTU $PFE $DUK $MLI #BTU #investing #tradeideas
22 May 15 21:34:06
AVXL Anavex Life Sciences Corp. Stock Message Board http://t.co/YNHHX6wCgQ $AVXL $PFE $BLTA $AGEN #AVXL #invest #pennystocks
22 May 15 21:32:24
ABX Barrick Gold Corp. Open http://t.co/UCBHMqSXHG $ABX $PFE $CLDN $V #ABX #pennystocks #investing
22 May 15 21:32:22
ABC AmerisourceBergen Corp. Financials http://t.co/rXK1o46wUg $ABC $AMZN $PFE $MOMO #ABC #finance #stocks
22 May 15 21:29:05
Find your own trading path. $MAT $TSM $IWM $PFE $GOOG $AAPL $DRC $LVS $CL $WTW $APC $GDX http://t.co/l9JkTCtpHR http://t.co/akHx5dnHpm
Invest | Donate
22 May 15 21:15:07
@PolgarStocks: SPXU ProShares UltraPro Short S&P 500 Filings http://t.co/GFvS2Bsvlw $SPXU $PFE $XLV $WFM #SPXU #stockmarket #invest
Investors Hangout
22 May 15 20:47:33
VDE Vanguard Energy VIPERs Prev Close http://t.co/rhfY3985yx $VDE $BABA $PFE $HPQ #VDE #investing #share
22 May 15 20:45:36
SPXU ProShares UltraPro Short S&P 500 Filings http://t.co/RdcffiGq6K $SPXU $PFE $XLV $WFM #SPXU #stockmarket #invest
Stock Forums
22 May 15 20:44:05
PFE Pfizer, Inc. EOD Data http://t.co/2eAhU26oea $PFE $FSS $MHYS $XIV #PFE #investing #nasdaq
22 May 15 20:43:05
NUGT Direxion Daily Gold Miners Bull 3x Shares Filings http://t.co/64xnbmXcY9 $NUGT $PFE $JDST $FEYE #NUGT #stockmarket #investing
22 May 15 20:08:06
One more before bed! Love ya'll! $MAT $TSM $IWM $PFE $DRC $LVS $CL $WTW $APC $GDX http://t.co/YU579z0Ece http://t.co/1h9igrj7hO
22 May 15 20:06:04
Unreal SKY tonight $MAT $TSM $IWM $PFE $DRC $LVS $CL $WTW $APC $GDX http://t.co/JUFJoVvAWo http://t.co/LsI0Yf7Ybh
22 May 15 19:54:18
bosocial: bosocial: leahanneta: TSLA Tesla Motors Inc. Open http://t.co/47Ez1Y1YOV $TSLA $URA $NYMX $PFE #TSLA … http://t.co/Csk7miIhta
22 May 15 19:53:23
RT @jamesdeyonker: $LPTN In light of failed study today, looks like $PFE will be on the hunt for an ocular replacement for its AMD loss. $…
22 May 15 19:51:21
bosocial: leahanneta: TSLA Tesla Motors Inc. Open http://t.co/47Ez1Y1YOV $TSLA $URA $NYMX $PFE #TSLA #nasdaq #i… http://t.co/Csk7miIhta
22 May 15 19:49:17
leahanneta: TSLA Tesla Motors Inc. Open http://t.co/47Ez1Y1YOV $TSLA $URA $NYMX $PFE #TSLA #nasdaq #investing http://t.co/Csk7miIhta
22 May 15 19:47:14
TXN Texas Instruments, Inc. Current Price http://t.co/c7cBENo9hR $TXN $AKS $PFE $BND #TXN #stocks #stocks
22 May 15 19:46:06
TSLA Tesla Motors Inc. Open http://t.co/AGFqYJTxxS $TSLA $URA $NYMX $PFE #TSLA #nasdaq #investing
Lucky Jimmy
22 May 15 19:43:06
PFE Pfizer, Inc. Ex-Div Date http://t.co/GkhL14cYzN $PFE $GOOG $CMG $IPGP #PFE #invest #stocks
Investors Hangout
22 May 15 19:31:09
ABC AmerisourceBergen Corp. Ask Size http://t.co/ze6Qw2Rk6k $ABC $VXX $TWTR $PFE #ABC #share #stockmarket
Clayton R.
22 May 15 18:33:03
Wondering where to learn stock options? Here's the place http://t.co/gV3ZaHH3uy $F $GE $T $BAC $VZ $C $AA $JPM $KO $PFE #investing
Lucky Jimmy
22 May 15 18:32:35
AMZN db X-Trackers Harvest CSI 300 China A-Shares Fund Company Info http://t.co/KApdCj8BSX $AMZN $EBR $PFE $BRWC #AMZN #stockmarket…
By  +Follow July 30, 2013 8:52AM



blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register